W08-028: Prostaglandin E2 Biosynthesis in Feline Mammary Cancers
In cats, mammary cancer accounts for up to 17% of all non-lymphoid tumors with an average age of occurrence at
Archives
W07-021: Molecular characterization of feline COX-2 and expression in mammary cancer
Mammary tumors are among the most common neoplasms in cats. Evidence indicates that cyclooxygenase-2 (COX-2), the rate-limiting enzyme in the
W04-033: EGFR and HERZ/neu expression in feline mammary gland adenocarcinoma and the effects of a novel EGFR inhibitor (Iressa®) on proliferation and apoptosis in vitro
Mammary gland tumors are a common tumor in the cat and most are highly aggressive tumors that will spread throughout